UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549

NOTICE OF EFFECTIVENESS

Effective Date:November 14,
NextCure (NASDAQ:NXTC)
Historical Stock Chart
From Apr 2024 to May 2024 Click Here for more NextCure Charts.
NextCure (NASDAQ:NXTC)
Historical Stock Chart
From May 2023 to May 2024 Click Here for more NextCure Charts.

Nextcure, Inc. News

NextCure Provides Business Update and Reports First Quarter 2024 Financial Results
Thursday 2 May 2024 (3 days ago) • GlobeNewswire Inc.
NextCure to Present Phase 1b Data of NC410 in Combination with Pembrolizumab at ASCO 2024
Wednesday 24 April 2024 (2 weeks ago) • GlobeNewswire Inc.
NextCure and LCB Present Preclinical Data on B7-H4 Antibody Drug Conjugate at AACR 2024
Monday 8 April 2024 (4 weeks ago) • GlobeNewswire Inc.
NextCure Appoints Dr. Rakesh Dixit to Scientific Advisory Board
Thursday 4 April 2024 (1 month ago) • GlobeNewswire Inc.
NextCure to Present at 23rd Annual Needham Virtual Healthcare Conference
Tuesday 2 April 2024 (1 month ago) • GlobeNewswire Inc.
NextCure Provides Business Update and Reports Full Year 2023 Financial Results
Thursday 21 March 2024 (1 month ago) • GlobeNewswire Inc.
NextCure Publishes Preclinical Data Demonstrating Function of FLRT3 as a T Cell Inhibitor in Science Advances
Tuesday 5 March 2024 (2 months ago) • GlobeNewswire Inc.
Form 4 - Statement of changes in beneficial ownership of securities
Thursday 1 February 2024 (3 months ago) • Edgar (US Regulatory)
Form 4 - Statement of changes in beneficial ownership of securities
Thursday 1 February 2024 (3 months ago) • Edgar (US Regulatory)
Form 4 - Statement of changes in beneficial ownership of securities
Thursday 1 February 2024 (3 months ago) • Edgar (US Regulatory)
Form 4 - Statement of changes in beneficial ownership of securities
Thursday 1 February 2024 (3 months ago) • Edgar (US Regulatory)
Form 4 - Statement of changes in beneficial ownership of securities
Thursday 1 February 2024 (3 months ago) • Edgar (US Regulatory)

More Nextcure, Inc. News Articles